Global Life Science and Chemical Instrumentation Market worth $45.2 Billion by 2016

Text-only Preview

Global Life Science and Chemical Instrumentation Market worth $45.2 Billion by 2016
The "Life Science and Chemical Instrumentation Market (2011 - 2016) (Spectroscopy,
Chromatography, DNA Sequencer & Amplifier, Lab Automation, Array, Flow Cytometer,
Electrophoresis, Immuno Assay & Others)" analyzes and studies the major market drivers,
restraints, and opportunities in regions such as U.S., Europe, Asia, and Rest of the world.
Browse market data tables and in-depth TOC on "Life Science and Chemical Instrumentation
Market (2011 - 2016) (Spectroscopy, Chromatography, DNA Sequencer & Amplifier, Lab
Automation, Array, Flow Cytometer, Electrophoresis, Immuno Assay & Others)".
http://www.marketsandmarkets.com/Market-Reports/life-science-chemical-biotech-
instrumentation-market-38.html
Early buyers will receive 10% customization of the report.
The global life science and instrumentation market was estimated to be $30.2 billion in the year
2011 and is expected to grow at a CAGR of 8.4% from 2011 to 2016 to reach $45.2 billion.
Spectrometry segment has the largest share (33.8%) followed by chromatography (22%) in the
year 2011. The spectrometry market is driven by the coupling of mass spectrometry with
chromatography techniques, growing at a CAGR of 7.4% from 2011 to 2016.
Life Sciences and chemical instruments are used to:

Develop new diagnostics, vaccines, and treatments to improve health

Lift agricultural productivity

Manage the environment through pollution and pest control and the use of organic
materials to generate energy

Assist with industrial innovation
Research and development is an essential part of life science and chemical industry. In the U.S.,
$25,101 million PPP (Purchasing Power Parity) was spend on the research and development by
the biotechnology firms, in 2010. In the year 2008, the total biotechnology companies were
1,452 in the U.S. and increased by 17% to reach 1,699 in the year 2009. In 2008, 20% of
pharmaceuticals were of biological origin, there are currently more than 200 biopharmaceutical

drugs available in the market for treating 400 indications, and at the same time, 300
biopharmaceuticals are under clinical trials. These are the major factors driving the market.
The major players of Life Science and Chemical Instrumentation Market include Affymetrix Inc.
(U.S.), Illumina Inc. (U.S.), Agilent Technologies Inc. (U.S.), Roche Diagnostics Inc. (Switzerland),
Bio-Rad Laboratories (U.S.), GE Healthcare (Sweden), Life Technologies (U.S.), Perkin Elmer
(U.S.), Caliper Life Sciences (U.S.), Shimadzu Corporation (Japan), Abbott Laboratories (U.S.),
Hitachi High-technologies Corporation (Japan), and Siemens Healthcare Diagnostics (Germany).
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We
publish strategically analyzed market research reports and serve as a business intelligence
partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. They cover thirteen industry verticals, including advanced materials,
automotives and transportation, banking and financial services, biotechnology, chemicals,
consumer goods, energy and power, food and beverages, industrial automation, medical
devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business
insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road, Suite 800,
Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]